Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction

Pedro Caraballo, Mark Parkulo, David Blair, Michelle Elliott, Cloann Schultz, Joseph Sutton, Padma Rao, Jamie Bruflat, Robert Bleimeyer, John Crooks, Donald Gabrielson, Wayne Nicholson, Carolyn Rohrer Vitek, Kelly Wix, Suzette J Bielinski, Jyotishman Pathak, Iftikhar Jan Kullo

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Citation (Scopus)

Abstract

The level of CYP2D6 metabolic activity can be predicted by pharmacogenomic testing, and concomitant use of clinical decision support has the potential to prevent adverse effects from those drugs metabolized by this enzyme. Our initial findings after implementation of clinical decision support alerts integrated in the electronic health records suggest high feasibility, but also identify important challenges.

Original languageEnglish (US)
Title of host publicationStudies in Health Technology and Informatics
PublisherIOS Press
Pages946
Number of pages1
Volume216
ISBN (Print)9781614995630
DOIs
StatePublished - 2015
Event15th World Congress on Health and Biomedical Informatics, MEDINFO 2015 - Sao Paulo, Brazil
Duration: Aug 19 2015Aug 23 2015

Publication series

NameStudies in Health Technology and Informatics
Volume216
ISSN (Print)09269630
ISSN (Electronic)18798365

Other

Other15th World Congress on Health and Biomedical Informatics, MEDINFO 2015
CountryBrazil
CitySao Paulo
Period8/19/158/23/15

Fingerprint

Clinical Decision Support Systems
Cytochrome P-450 CYP2D6
Drug Interactions
Enzymes
Genes
Health
Electronic Health Records
Testing
Pharmaceutical Preparations
Pharmacogenetics

Keywords

  • Clinical Decision Support Systems
  • Cytochrome P-450 CYP2D6
  • Electronic Health Records
  • Pharmacogenomics

ASJC Scopus subject areas

  • Biomedical Engineering
  • Health Informatics
  • Health Information Management

Cite this

Caraballo, P., Parkulo, M., Blair, D., Elliott, M., Schultz, C., Sutton, J., ... Kullo, I. J. (2015). Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction. In Studies in Health Technology and Informatics (Vol. 216, pp. 946). (Studies in Health Technology and Informatics; Vol. 216). IOS Press. https://doi.org/10.3233/978-1-61499-564-7-946

Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction. / Caraballo, Pedro; Parkulo, Mark; Blair, David; Elliott, Michelle; Schultz, Cloann; Sutton, Joseph; Rao, Padma; Bruflat, Jamie; Bleimeyer, Robert; Crooks, John; Gabrielson, Donald; Nicholson, Wayne; Rohrer Vitek, Carolyn; Wix, Kelly; Bielinski, Suzette J; Pathak, Jyotishman; Kullo, Iftikhar Jan.

Studies in Health Technology and Informatics. Vol. 216 IOS Press, 2015. p. 946 (Studies in Health Technology and Informatics; Vol. 216).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Caraballo, P, Parkulo, M, Blair, D, Elliott, M, Schultz, C, Sutton, J, Rao, P, Bruflat, J, Bleimeyer, R, Crooks, J, Gabrielson, D, Nicholson, W, Rohrer Vitek, C, Wix, K, Bielinski, SJ, Pathak, J & Kullo, IJ 2015, Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction. in Studies in Health Technology and Informatics. vol. 216, Studies in Health Technology and Informatics, vol. 216, IOS Press, pp. 946, 15th World Congress on Health and Biomedical Informatics, MEDINFO 2015, Sao Paulo, Brazil, 8/19/15. https://doi.org/10.3233/978-1-61499-564-7-946
Caraballo P, Parkulo M, Blair D, Elliott M, Schultz C, Sutton J et al. Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction. In Studies in Health Technology and Informatics. Vol. 216. IOS Press. 2015. p. 946. (Studies in Health Technology and Informatics). https://doi.org/10.3233/978-1-61499-564-7-946
Caraballo, Pedro ; Parkulo, Mark ; Blair, David ; Elliott, Michelle ; Schultz, Cloann ; Sutton, Joseph ; Rao, Padma ; Bruflat, Jamie ; Bleimeyer, Robert ; Crooks, John ; Gabrielson, Donald ; Nicholson, Wayne ; Rohrer Vitek, Carolyn ; Wix, Kelly ; Bielinski, Suzette J ; Pathak, Jyotishman ; Kullo, Iftikhar Jan. / Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction. Studies in Health Technology and Informatics. Vol. 216 IOS Press, 2015. pp. 946 (Studies in Health Technology and Informatics).
@inproceedings{475c137025c44c668d0f556f2090ebf2,
title = "Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction",
abstract = "The level of CYP2D6 metabolic activity can be predicted by pharmacogenomic testing, and concomitant use of clinical decision support has the potential to prevent adverse effects from those drugs metabolized by this enzyme. Our initial findings after implementation of clinical decision support alerts integrated in the electronic health records suggest high feasibility, but also identify important challenges.",
keywords = "Clinical Decision Support Systems, Cytochrome P-450 CYP2D6, Electronic Health Records, Pharmacogenomics",
author = "Pedro Caraballo and Mark Parkulo and David Blair and Michelle Elliott and Cloann Schultz and Joseph Sutton and Padma Rao and Jamie Bruflat and Robert Bleimeyer and John Crooks and Donald Gabrielson and Wayne Nicholson and {Rohrer Vitek}, Carolyn and Kelly Wix and Bielinski, {Suzette J} and Jyotishman Pathak and Kullo, {Iftikhar Jan}",
year = "2015",
doi = "10.3233/978-1-61499-564-7-946",
language = "English (US)",
isbn = "9781614995630",
volume = "216",
series = "Studies in Health Technology and Informatics",
publisher = "IOS Press",
pages = "946",
booktitle = "Studies in Health Technology and Informatics",

}

TY - GEN

T1 - Clinical Decision Support to Implement CYP2D6 Drug-Gene Interaction

AU - Caraballo, Pedro

AU - Parkulo, Mark

AU - Blair, David

AU - Elliott, Michelle

AU - Schultz, Cloann

AU - Sutton, Joseph

AU - Rao, Padma

AU - Bruflat, Jamie

AU - Bleimeyer, Robert

AU - Crooks, John

AU - Gabrielson, Donald

AU - Nicholson, Wayne

AU - Rohrer Vitek, Carolyn

AU - Wix, Kelly

AU - Bielinski, Suzette J

AU - Pathak, Jyotishman

AU - Kullo, Iftikhar Jan

PY - 2015

Y1 - 2015

N2 - The level of CYP2D6 metabolic activity can be predicted by pharmacogenomic testing, and concomitant use of clinical decision support has the potential to prevent adverse effects from those drugs metabolized by this enzyme. Our initial findings after implementation of clinical decision support alerts integrated in the electronic health records suggest high feasibility, but also identify important challenges.

AB - The level of CYP2D6 metabolic activity can be predicted by pharmacogenomic testing, and concomitant use of clinical decision support has the potential to prevent adverse effects from those drugs metabolized by this enzyme. Our initial findings after implementation of clinical decision support alerts integrated in the electronic health records suggest high feasibility, but also identify important challenges.

KW - Clinical Decision Support Systems

KW - Cytochrome P-450 CYP2D6

KW - Electronic Health Records

KW - Pharmacogenomics

UR - http://www.scopus.com/inward/record.url?scp=84952011706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952011706&partnerID=8YFLogxK

U2 - 10.3233/978-1-61499-564-7-946

DO - 10.3233/978-1-61499-564-7-946

M3 - Conference contribution

C2 - 26262248

AN - SCOPUS:84952011706

SN - 9781614995630

VL - 216

T3 - Studies in Health Technology and Informatics

SP - 946

BT - Studies in Health Technology and Informatics

PB - IOS Press

ER -